Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, May 27, 2011

Biomarker to tackle cardiovascular risk in older people?

http://www.barchester.com/Healthcare-News/Biomarker-to-tackle-cardiovascular-risk-in-older-people%3F/376/4438
A biomarker for cardiovascular conditions has identified a possible therapeutic target for heart failure.
Older patients, possible home care users, who have symptoms of heart failure and a certain biomarker in the blood have an associated increased risk of death, according to new findings.
A study published in journal JAMA found that increased concentrations in the blood of biomarker copeptin or a combination of high levels of copeptin concentrations and biomarker NT-proBNP, along with symptoms of heart failure, caused an increased risk of all-cause death.
Copeptin could be a potential surrogate marker for measurement of vasopressin - a cardiovascular disease marker - in the blood.
According to authors: "These data, together with our findings of the prognostic information provided by measurement of copeptin concentrations in elderly patients with symptoms of heart failure, suggest that vasopressin may be a potential target for therapeutic intervention."
This follows Johns Hopkins research which revealed that when a stroke occurs, a 'survival protein' is produced in the brain in order to protect cells
My next post refers to this survival protein

No comments:

Post a Comment